Instem PLC
LSE:INS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Net Margin
Instem PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| UK |
|
Instem PLC
LSE:INS
|
190m GBP |
6%
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
39.1B USD |
28%
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
10%
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
22.5B AUD |
52%
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.4T JPY |
14%
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
8.6B USD |
41%
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
5.7B USD |
11%
|
|
| SE |
|
Sectra AB
STO:SECT B
|
45.5B SEK |
29%
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
286.4B INR |
18%
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
20.3B CNY |
-14%
|
|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
2.8B USD |
5%
|
Instem PLC
Glance View
Instem Plc engages in the provision of information technology solutions and services to the global health and life sciences community. The company is headquartered in Stone, Staffordshire and currently employs 304 full-time employees. The company went IPO on 2010-10-13. The firm operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trials Acceleration. Its Study Management Solutions is a software that enables organizations to collect, review, manage and report discovery and preclinical report. Its Regulatory Solutions is a software, outsourced services and consultancy for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The firm's In Silico Solutions enables researchers to generate scientific insights through identification, extraction and analysis of information. Its Clinical Trials Acceleration Solutions is a technology solution and consulting service to facilitate data integration, statistics, analytics and insights for companies any size or stage of clinical trial analysis.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Instem PLC's most recent financial statements, the company has Net Margin of 5.6%.